A potent weapon against lymphomas
Researchers from the The Max Delbrück Center (MDC) for Molecular Medicine in the Helmholtz Association…
Browsing: Chronic Lymphocytic Leukaemia
New analysis method for predicting the risks and effects of immunotherapy
In a new study, researchers at Uppsala University, Sweden, have been able to show differences…
Benefits of Venetoclax endure years after blood cancer clinical trial
A study which tracked the long-term outcomes of blood cancer patients involved in the MURANO…
New prognostic tool helps leukaemia patients plan for cancer treatment
First validated prognostic score offers valuable insights for patients advised to ‘watch and wait’ A…
Clive James raised awareness of leukaemia, part of his rich and valuable legacy
Ian Olver, University of Adelaide Clive James has left a valuable legacy of astute observation…
Prime Minister’s science prizes awarded for algebra expertise, anti-cancer research and excellence in science teaching
Michael Hopkin, The Conversation and Noor Gillani, The Conversation The 2019 Prime Minister’s Prize for…
Drug combo heralds major shift in chronic lymphocytic leukaemia treatment
A combination of two drugs keeps patients with chronic lymphocytic leukaemia disease-free and alive longer…
Hidden chemistry in flowers shown to kill cancer cells
Researchers at the University of Birmingham have shown that it’s possible to produce a compound…
EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia
The Phase III ASCEND study of the Bruton’s Tyrosine Kinase inhibitor (BTKi) acalabrutinib in relapsed…
Patterns of chronic lymphocytic leukaemia growth identified
In patients with chronic lymphocytic leukaemia (CLL), the rate of disease growth is apt to…